CAR-Ts that grow on trees: Automating cell therapy manufacturing
As the cell and gene therapies market evolves, CDMOs and pharmaceutical companies aim to adapt to the rising demands and serve larger patient populations.
As the cell and gene therapies market evolves, CDMOs and pharmaceutical companies aim to adapt to the rising demands and serve larger patient populations.
The global single-use bioprocessing market is projected to grow to be worth $7bn by 2024, according to a recent report.
Utilising single-use flow paths, Fujifilm will create a continuous bioprocessing manufacturing facility after three years of in-house development.
WuXi Biologics has selected its construction partner, Jacobs, for the building stage of its ‘Factory of the Future’ facility in Dundalk, Ireland.
Thermo Fisher invests into bioproduction capabilities as ‘single use continues to reshape the face of the industry,’ says single-use technology executive.
Merck acquires Tilos, a biopharmaceutical developer targeting the latent TGFβ complex for the treatment of cancer, fibrosis and autoimmune diseases.
UPDATED
An executive at Samsung is issued an arrest warrant, as prosecutors in South Korea continue to look into the accounting case leading up the IPO of Samsung BioLogics.
Servier to work with Yposeski for the production of lentiviral vectors, as the former works to develop allogenic CAR-T cell technology for hematological therapies.